Rapport Therapeutics, Inc. Common Stock (RAPP) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Rapport Therapeutics, Inc. Common Stock (RAPP) quarterly balance sheet — complete assets, liabilities & equity history

Quarterly statement

RAPP Balance Sheet

Rapport Therapeutics, Inc. Common Stock (RAPP) balance sheet — 4-year assets, liabilities & shareholders' equity history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23

Total Current Assets	446.86M	484.69M	498.56M	520.66M	270.24M	290.97M	309.8M	325.94M	340.67M	198.73M	150.87M
Cash & Short-Term Investments	436.08M	476.78M	490.54M	513.03M	260.45M	285.38M	305.28M	320.66M	336.14M	193.24M	147.48M
Cash Only	63.61M	78.06M	52.65M	251.36M	55.07M	57.6M	56.8M	39.31M	110.16M	74.27M	70.17M
Short-Term Investments	372.46M	398.73M	437.89M	261.67M	205.38M	227.78M	248.47M	281.35M	225.97M	118.98M	77.31M
Accounts Receivable	293K	58K	0	0	0	0	0	0	0	0	0
Days Sales Outstanding	-	0.26	-	-	-	-	-	-	-	-	-
Inventory	0	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	105K	7.86M	8.02M	7.63M	9.79M	5.59M	4.52M	5.28M	4.53M	5.48M	3.39M
Total Non-Current Assets	12.13M	12.9M	13.87M	14.66M	15.25M	11.09M	5.13M	5.21M	5.43M	7.56M	4.55M
Property, Plant & Equipment	11.07M	11.85M	12.88M	13.6M	14.22M	10.87M	4.97M	5.02M	5.24M	5.49M	4M
Fixed Asset Turnover	-	1.62x	-	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	1.06M	1.06M	985K	1.07M	1.03M	211K	160K	189K	189K	2.07M	551K
Total Assets	458.98M	497.6M	512.43M	535.32M	285.5M	302.05M	314.93M	331.14M	346.1M	206.29M	155.42M
Asset Turnover	-	0.04x	-	-	-	-	-	-	-	-	-
Asset Growth %	60.77%	64.74%	62.71%	61.66%	-17.51%	46.42%	102.63%	-	-	-	-
Total Current Liabilities	28.42M	17.9M	19.05M	14.32M	11.88M	9.38M	8.77M	7.1M	8.1M	9.88M	8.8M
Accounts Payable	2.8M	6.56M	4.19M	3.23M	3.18M	2.14M	1.95M	1.32M	1.88M	1.45M	2.5M
Days Payables Outstanding	-	-	-	-	-	-	-	-	-	-	12.02K
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	4.25M	3.08M	7.12M	5.04M	3.14M	2.1M	3.71M	3.23M	1.71M	1.04M	2.41M
Current Ratio	15.72x	27.08x	26.17x	36.37x	22.75x	31.01x	35.34x	45.91x	42.08x	20.10x	17.14x
Quick Ratio	15.72x	27.08x	26.17x	36.37x	22.75x	31.01x	35.34x	45.91x	42.08x	20.10x	17.14x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	7.63M	8.19M	8.73M	9.39M	10.1M	6.83M	739K	931K	1.12M	236.04M	172.25M
Long-Term Debt	0	8.19M	8.73M	9.39M	0	0	0	0	0	0	0
Capital Lease Obligations	7.63M	0	0	0	10.1M	6.83M	739K	931K	1.12M	1.3M	1.48M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	234.74M	170.78M
Total Liabilities	36.06M	26.09M	27.78M	23.71M	21.98M	16.22M	9.51M	8.03M	9.21M	245.92M	181.06M
Total Debt	10.11M	10.8M	11.48M	11.87M	11.86M	7.84M	1.48M	1.65M	1.82M	1.98M	2.15M
Net Debt	-53.51M	-67.25M	-41.16M	-239.49M	-43.2M	-49.76M	-55.33M	-37.66M	-108.34M	-72.28M	-68.02M
Debt / Equity	0.02x	0.02x	0.02x	0.02x	0.05x	0.03x	0.00x	0.01x	0.01x	-	-
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-	-	-	-	-	-	-
Total Equity	422.93M	471.51M	484.65M	511.62M	263.51M	285.84M	305.43M	323.11M	336.89M	-39.63M	-25.63M
Equity Growth %	60.5%	64.96%	58.68%	58.34%	-21.78%	821.21%	1291.49%	-	-	-	-
Book Value per Share	8.91	9.98	10.32	13.49	7.43	14.82	15.83	16.85	16.75	-2.04	-1.42
Total Shareholders' Equity	422.93M	471.51M	484.65M	511.62M	263.51M	285.84M	305.43M	323.11M	336.89M	-39.63M	-25.63M
Common Stock	48K	48K	48K	48K	37K	37K	37K	36K	36K	4K	4K
Retained Earnings	-311.7M	-255.09M	-235.23M	-201.47M	-174.54M	-147.81M	-123.75M	-103.77M	-86.23M	-68.11M	-45.44M
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-1.27M	-505K	546K	145K	-76K	-95K	-522K	400K	-183K	-160K	4K
Minority Interest	0	0	0	0	0	0	0	0	0	0	0